Yahoo
NasdaqGS - Nasdaq Real Time Price USD

Neogen Corporation (NEOG)

12.11 +0.34 (+2.93%)
As of 11:44:07 AM EST. Market Open.
Trade Neogen on Coinbase

Key Executives

Amounts are as of December 31, 2026 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
Name Title Pay Exercised Year Born
Mr. Mikhael Nassif
CEO, President & Director 2.19M -- 1976
Mr. R. Bryan Riggsbee CPA
CFO & Senior Vice President 1.09M -- 1970
Ms. Jennifer Evans Stacey Esq., J.D.
Senior VP, Chief Legal & Compliance Officer and Board Secretary 434.19k -- 1965
Dr. Tamara A. Ranalli Ph.D.
Senior VP & GM of Global Food Safety 648.85k -- 1973
Mr. John Moylan
VP, Corporate Controller & Chief Accounting Officer -- -- --
Dr. Jeremy Yarwood
Chief Scientific Officer -- -- --
Sarah Demey
Administrative Manager -- -- --
Mr. Kevin M. Burke
Chief Human Resources Officer -- -- 1969
Mr. Joe Freels
Senior VP & Chief Commercial Officer -- -- --
Mr. Jim Walter
Senior Vice President of Manufacturing & Operations -- -- --

Neogen Corporation

620 Lesher Place
Lansing, MI 48912-1595
United States
517 372 9200 https://www.neogen.com
Sector: 
Healthcare
Industry: 
Medical Devices
Full Time Employees: 
2,636

Description

Neogen Corporation develops, manufactures, and markets various products and services for food and animal safety in the United States and internationally. It operates through Food Safety and Animal Safety segments. The company offers diagnostic test kits and complementary products to detect dangerous and/or unintended substances in human food and animal feed, such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns. It also provides reagents and test kits used in immunoassay production, forensic and animal toxicology, and life science research; unique colorimetric and chemiluminescent substrates for research use; veterinary instruments and delivery systems under the Ideal and Prima Tech brands; and precision instruments designed for injections, topical and oral administration, artificial insemination, and animal identification for farmers, ranchers, and veterinarian under the Prima Tech brand. In addition, the company offers digestive aids and nutritional supplements; Natural Vitamin E-AD to address vitamin deficiencies in swine, cattle, and sheep; RenaKare; companion animal parasiticides under Provecta brand; BotVax B; EqStim; ImmunoRegulin; companion animal parasiticides under the Provecta brand; rodent and insect control products under the Ramik, CyKill, Havoc, Prozap, SureKill, and StandGuard brands. Further, it markets Uniprim, a veterinary antibiotic; operates sgenomics labs offering DNA genotyping, sequencing, and trait analysis for livestock and companion animals; and provides software systems that help testers to analyze and store results and perform analysis. The company has a strategic collaboration with Hinalea Imaging Corp. to develop digital imaging solutions for food safety and quality inspection. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan.

Corporate Governance

Neogen Corporation’s ISS Governance QualityScore as of November 1, 2026 is 5. The pillar scores are Audit: 9; Board: 2; Shareholder Rights: 6; Compensation: 6.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

January 7, 2027 at 9:00 PM UTC

Neogen Corporation Earnings Date

Recent Events

October 26, 2026 at 12:00 AM UTC

8-K/A: Corporate Changes & Voting Matters

October 20, 2026 at 12:00 AM UTC

S-8: Offering Registrations

October 7, 2026 at 12:00 AM UTC

10-Q: Periodic Financial Reports

October 6, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

September 28, 2026 at 12:00 AM UTC

DEFA14A: Proxy Statements

August 21, 2026 at 12:00 AM UTC

ARS: Annual Report to Shareholders

August 7, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

July 30, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

June 25, 2026 at 12:00 AM UTC

11-K: Annual report of employee stock purchase

May 20, 2026 at 12:00 AM UTC

SD: Specialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: